光莆股份(300632.SZ):兩個紫外消毒殺菌產品完成消毒產品衞生安全評價備案
格隆匯 7 月 8日丨光莆股份(300632.SZ)公佈,近期,公司部分紫外消毒殺菌產品相繼完成了消毒產品衞生安全評價備案,產品名稱:GOPRO®GP-UV-LXX型紫外殺菌燈;GOPRO®GP-UV-A02Y-100型空氣消毒機。
公司上述紫外消毒殺菌產品通過消毒產品衞生安全評價備案,獲得了在國內市場銷售的准入條件,且上述紫外殺菌燈已通過FCC認證,Y-100空氣消毒機已通過CE認證,上述產品具備了出口海外市場的准入條件,有利於上述產品在國內外市場的推廣和銷售,增強公司紫外消毒殺菌產品的競爭力和影響力。
截至2020年6月30日,該系列產品業務收入約為400萬元,在公司總營收中的佔比較小,尚未對公司業績構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.